WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013056197) DEGRADATION RESISTANT HSP70 FORMULATIONS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/056197    International Application No.:    PCT/US2012/060157
Publication Date: 18.04.2013 International Filing Date: 13.10.2012
IPC:
A61K 38/17 (2006.01), A61K 9/16 (2006.01)
Applicants: ALTERNATIVE INNOVATIVE TECHNOLOGIES LLC [US/US]; 118 Dent Street West Roxbury, MA 02132 (US) (For All Designated States Except US).
ONIKIENKO, Sergei B. [RU/RU]; (RU).
NIVOROZHKIN, Alex [US/US]; (US)
Inventors: ONIKIENKO, Sergei B.; (RU).
NIVOROZHKIN, Alex; (US)
Agent: WEINTRAUB, Jacob G.; Jwip & Patent Services, LLC 670 Depot Street PO Box 1265 Easton, MA 02334 (US)
Priority Data:
61/547,039 14.10.2011 US
Title (EN) DEGRADATION RESISTANT HSP70 FORMULATIONS AND USES THEREOF
(FR) FORMULATIONS D'HSP70 RÉSISTANTES À LA DÉGRADATION ET LEURS UTILISATIONS
Abstract: front page image
(EN)The present invention relates to novel therapies that utilize stabilized exogenous HSP70 for the treatment of disorders or conditions regulated by HSP70 through administration of degradation resistant formulations of HSP70. Furthermore, the present invention is directed to methods comprising the administration of stabilized exogenous HSP70 for use in the treatment of HSP70 related disorders or conditions, for example, for increased endurance or alleviating fatigue syndrome.
(FR)La présente invention concerne de nouvelles thérapies qui utilisent l'HSP70 exogène stabilisé pour le traitement de troubles ou d'états régulés par HSP70, par l'intermédiaire de l'administration de formulations résistantes à la dégradation d'HSP70. De plus, la présente invention concerne des procédés qui comporte l'administration d'HSP70 exogène stabilisé à utiliser dans le traitement de troubles ou d'états associés à HSP70, par exemple pour une augmentation de l'endurance ou l'atténuation d'un syndrome de fatigue.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)